Braskem Creditors Demand $3B Equity Injection, Reject Restructuring Plan
BAK sits 25% above its 52-week low of $1.4.
Summary
Creditors are demanding that controlling shareholders Petrobras and IG4 Capital inject $3B in fresh equity into Braskem, rejecting the company's late-August restructuring plan that sought $2B from creditors. Bondholders insist on a legally binding pledge from the owners and refuse to contribute new funds, while Petrobras resists enforceable guarantees. This escalation follows Braskem's extrajudicial reorganization filing covering $10.9B in unsecured debt and a Fitch downgrade to restricted default. The standoff raises the prospect of a formal bankruptcy filing, which would likely wipe out equity holders. Watch for any counterproposal from creditors or a court ruling on the emergency protection.
At the time of this announcement, BAK was trading at $1.75 on NYSE in the Manufacturing sector, with a market capitalization of approximately $645.8M. The 52-week trading range was $1.40 to $5.40. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Seeking Alpha.